EPOCH Chemotherapy and Bortezomib for Associated T-Cell Leukemia Lymphoma
Phase I/II Trial of Dose-Adjusted EPOCH Chemotherapy With Bortezomib Combined With Integrase Inhibitor Therapy for HTLV-1 Associated T-Cell Leukemia Lymphoma Phase I/II Trial of Dose-Adjusted EPOCH Chemotherapy With BortezomibCombined With Integrase Inhibito ...